Art

J-GLOBAL ID：201702218186758457   Reference number：17A1403559

多発性骨髄腫の最新情報:総論

Author (2)： KASAMATSU TETSUHIRO (群馬大 大学院保健学研究科) ,  MURAKAMI HIROKAZU (群馬大 大学院保健学研究科)
Material： Vita
Volume： 34  Issue： 4  Page： 40-45  Publication year： Oct. 2017 
JST Material Number： L5257A  ISSN： 0915-1028  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human ,...
Semi thesaurus term： immunoelectrophoresis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1403559&from=J-GLOBAL&jstjournalNo=L5257A") }}

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Clinical oncology in general  (GE03010Y)

Substance index (1)： Thalidomide

Reference (9)：

• Solly S: Remarks on the pathology of mollities ossium with cases. Med-chir Tr 1844; 27: 435-461.
• Bence Jones H: On a new substance occurring in the urine of a patient with mollities ossium. Phil Trans Royal Soc (London) 1848; 1: 55-62.
• von Rustizkyon Rustizky, J. Multiples myelom. Deutsche Zeitschrift fuÈr Chirurgie 1873; 3; 162-172.
• Palumbo A, Rajkumar SV, San Miguel JF, et al: International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol 2014; 32: 587-600.
• Greipp PR, San Miguel J, Durie BG, et al: International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-3420.

Terms in the title (2)： 多発性骨髄腫 ,  最新情報